Literature DB >> 3873618

Human transforming growth factor-alpha causes precocious eyelid opening in newborn mice.

J M Smith, M B Sporn, A B Roberts, R Derynck, M E Winkler, H Gregory.   

Abstract

Both murine and human epidermal growth factors (EGFs) are known to cause precocious opening of the eyelids in newborn mice. Another set of peptides that are structurally and functionally homologous to murine and human EGFs are the murine and human type-alpha transforming growth factors (TGF-alpha s), TGF-alpha s have been found in many cancer cells and it has been suggested that their autocrine action may play an important part in malignant transformation. In several in vitro systems murine and human TGF-alpha s are functionally interchangeable with murine and human EGFs. However, the in vivo activity of the TGF-alpha s has not been characterized, as only small amounts of these peptides were available until recently. The cloning of the gene for human TGF-alpha and its expression in Escherichia coli now allow us to demonstrate that human TGF-alpha is as active as murine EGF in promoting eyelid opening in newborn mice. Furthermore, we show in a dose-dependent eyelid opening assay that human EGF is as potent as its murine homologue with respect to this biological property.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873618     DOI: 10.1038/315515a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  17 in total

1.  Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.

Authors:  R Ebner; R Derynck
Journal:  Cell Regul       Date:  1991-08

Review 2.  Angiogenic growth factors in neural embryogenesis and neoplasia.

Authors:  D Zagzag
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

3.  Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells.

Authors:  R A Ignotz; B Kelly; R J Davis; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Authors:  A B Roberts; M B Sporn; R K Assoian; J M Smith; N S Roche; L M Wakefield; U I Heine; L A Liotta; V Falanga; J H Kehrl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Insulin-like synergistic stimulation of DNA synthesis in Swiss 3T3 cells by the BSC-1 cell-derived growth inhibitor related to transforming growth factor type beta.

Authors:  K D Brown; R W Holley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  Epidermal growth factor acts as a corticotropin-releasing factor in chronically catheterized fetal lambs.

Authors:  D H Polk; M G Ervin; J F Padbury; R W Lam; A L Reviczky; D A Fisher
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

Review 7.  Potential role of the epidermal growth factor receptor in human pancreatic cancer.

Authors:  M Korc
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

8.  SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.

Authors:  Lieven Huang; Lea Olive Tchouate Gainkam; Vicky Caveliers; Chris Vanhove; Marleen Keyaerts; Patrick De Baetselier; Axel Bossuyt; Hilde Revets; Tony Lahoutte
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

9.  Identification of two anti-parallel beta-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance.

Authors:  G T Montelione; K Wüthrich; E C Nice; A W Burgess; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures.

Authors:  N Takahashi; B R MacDonald; J Hon; M E Winkler; R Derynck; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.